Related Articles
Ibrutinib in CLL/SLL: From bench to bedside (Review)
Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B‑cell malignancies (Review)
New emerging therapies in the management of chronic lymphocytic leukemia (Review)
Management of patients with chronic lymphocytic leukemia during the SARS‑CoV‑2 pandemic (Review)
CD14+HLA-DRlow/‑ expression: A novel prognostic factor in chronic lymphocytic leukemia